| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |